Skip to main content

Lifevantage Corp

corporate_fare Company Profile

Lifevantage Corp

LFVN·NASDAQ·Life Sciences·CIK 0000849146

LifeVantage Corporation focuses on nutrigenomics, studying how nutrition and natural compounds affect human genes for health. The company provides scientifically validated products and a commission-based direct sales opportunity to independent consultants. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and Singapore, as well as to customers for personal consumption in other countries. The company identifies, researches, develops, formulates, and sells advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. Key product lines include Protandim®, a flagship line of dietary supplements; LifeVantage®, which offers dietary supplements such as the MindBody GLP-1 System™, Omega+, ProBio, IC Bright®, the Rise AM & Reset PM System®, D3+, and Daily Wellness; PhysIQ™, providing Fat Burn and Prebiotic dietary supplements; TrueScience®, a line of skin and hair care products and Liquid Collagen; Petandim®, a companion pet supplement for dogs; and AXIO®, nootropic energy drink mixes. LifeVantage was incorporated in Colorado in June 1988 and operated under various names before becoming LifeVantage Corporation in November 2006. From fiscal year 2005 until fiscal year 2009, the company marketed and sold Protandim® through traditional retail stores.

Lifevantage Corp (NASDAQ:LFVN) is a publicly traded company in the Life Sciences sector. Wiseek monitors LFVN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • LifeVantage Reports Steep Q3 Revenue & Profit Declines, Lowers Guidance Amidst Operational Challenges
  • LifeVantage Reports Steep Q3 Revenue & Profit Decline, Active Accounts Drop 22%, Cash Drains
  • LifeVantage Q3 Revenue Plunges 25%, Profits Halved Amid 'Softer Than Anticipated' Results
  • U.S. Patent Granted to LifeVantage for Healthy Glow Essentials Stack, Bolstering IP
  • LifeVantage Appoints Terrence Moorehead as CEO, Details Substantial Compensation

Financial Snapshot

Fiscal year ended June 30, 2025
Revenue
$228.53M
Net Income
$9.8M
Diluted EPS
$0.75
Op. Cash Flow
$11.88M
Free Cash Flow
$10.51M
Gross Profit
$183.67M
Operating Income
$12.2M
Cash & Equivalents
$20.2M
Debt / Equity
0.00×
Net Margin
4.3%
Shares Outstanding
12.43M sh
Source: 10-K · filed 2025-09-04 · accession 0000849146-25-000068
Browse all tickers starting with L →
$9.15 +0.10% today
52-week range · as of 2026-05-06 $3.9 – $15
Market cap
$114.17M
Volume
504.3K (0.8× avg)
3-mo avg 626.6K
Live data · 2026-06-12 23:08 UTC · After hours

show_chartPrice Chart

Loading chart...

feed LFVN - Latest Insights

LFVN
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $9.15 info
Change: +$4.25 (+87%) info
Market Cap: $114.173M info
LFVN
May 06, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.90
Real-time Price: $9.15 info
Change: +$4.25 (+87%) info
Market Cap: $114.173M info
LFVN
May 06, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $5.14
Real-time Price: $9.15 info
Change: +$4.01 (+78%) info
Market Cap: $114.173M info
LFVN
Apr 21, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.25
Real-time Price: $9.15 info
Change: +$3.90 (+74%) info
Market Cap: $114.173M info
LFVN
Apr 16, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.57
Real-time Price: $9.15 info
Change: +$4.58 (+100%) info
Market Cap: $114.173M info
LFVN
Apr 02, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $9.15 info
Change: +$4.95 (+118%) info
Market Cap: $114.173M info
LFVN
Mar 02, 2026, 6:44 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $4.64
Real-time Price: $9.15 info
Change: +$4.51 (+97%) info
Market Cap: $114.173M info
LFVN
Feb 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.78
Real-time Price: $9.15 info
Change: +$5.37 (+142%) info
Market Cap: $114.173M info
LFVN
Feb 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.78
Real-time Price: $9.15 info
Change: +$5.37 (+142%) info
Market Cap: $114.173M info